| Literature DB >> 19088854 |
Joep P M Derikx1, Dick A van Waardenburg, Geertje Thuijls, Henriëtte M Willigers, Marianne Koenraads, Annemarie A van Bijnen, Erik Heineman, Martijn Poeze, Ton Ambergen, André van Ooij, Lodewijk W van Rhijn, Wim A Buurman.
Abstract
BACKGROUND: Gut barrier loss has been implicated as a critical event in the occurrence of postoperative complications. We aimed to study the development of gut barrier loss in patients undergoing major non-abdominal surgery. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2008 PMID: 19088854 PMCID: PMC2599890 DOI: 10.1371/journal.pone.0003954
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic, surgical and fluid balance characteristics.
| No | Age (y) | Weight (kg) | Surgery | Duration surgery (hr) | History | Early complications | Blood loss (ml/kg) | Fluid in (ml/kg) | Diuresis (ml/kg/hr) | Mean (range) MAP (mmHg) | Mean (range) lactate (mmol/l) |
| 1 | 8 | 36 | ASF T7-L4 | 6 | spina bifida, hydrocephalus | fever, UTI | 14 | 103 | 3.5 | 57 (52–63) | 1.0 (0.8–1.2) |
| 2 | 15 | 40 | ASF+PSF T3-S1 | 8 | cerebral palsy, spastic diplegia, IVH | 20 | 131 | 1.7 | 54 (41–66) | 1.2 (1.0–1.3) | |
| 3 | 12 | 51 | ASF+PSF T12-L3 | 8 | - | fever, pneumonia | 59 | 163 | 1.1 | 56 (50–66) | 1.9 (1.6–2.6) |
| 4 | 12 | 31 | ASF+PSF T2-S1 | 9 | DiGeorge syndrome; vascular spinal cord lesion | melaena | 32 | 190 | 1.5 | 59 (45–77) | 1.6 (0.8–1.9) |
| 5 | 13 | 59 | PSF T4-L3 | 6 | cleft lip nose deformity | - | 53 | 156 | 2.5 | 65 (56–70) | 1.3 (1.2–1.4) |
| 6 | 11 | 37 | PSF T3-T12 | 4 | spina bifida occulta | - | 11 | 95 | 1.5 | 81 (70–95) | 1.8 (1.6–2.1) |
| 7 | 8 | 45 | PSF T2-L5 | 4 | spinal muscular atrophy | - | 14 | 68 | 1.9 | 55 (51–60) | 0.9 (0.7–1.1) |
| 8 | 10 | 48 | ASF T6-T12 | 4 | - | - | 13 | 73 | 4.2 | 66 (59–75) | 1.5 (1.2–1.9) |
| 9 | 14 | 33 | PSF T3-S1 | 8 | spastic tetraplegia, panencephalitis | - | 91 | 341 | 5.3 | 65 (51–80) | 1.2 (0.8–1.5) |
| 10 | 15 | 55 | ASF T6-T12 | 4 | - | - | 5 | 109 | 1.2 | 79 (70–101) | 2.6 (1.6–3.5) |
| 11 | 2 | 9 | ASF T12-L2 | 2 | Conradi-Hünermann-Happle syndrome | - | 1 | 34 | 0.3 | 58 (51–70) | 1.4 (1.1–1.6) |
| 12 | 10 | 22 | ASF+PSF T2-S1 | 7 | cerebral palsy, spastic tertraparesis | - | 9 | 203 | 1.3 | 50 (39–56) | 1.3 (1.1–1.5) |
| 13 | 15 | 82 | ASF+PSF T3-L3 | 7.5 | - | fever, wound infection | 30 | 103 | 2.5 | 64 (53–88) | 1.1 (0.9–1.2) |
| 14 | 16 | 54 | ASF T7-T12 | 4 | - | - | 4 | 56 | 0.8 | 71 (63–82) | 0.8 (0.6–1.3) |
| 15 | 13 | 20 | PSF T2-S1 | 8 | spina bifida; Arnold Chiari type 2 malformation | peroperative anaphylactic shock to Venofundin | 75 | 180 | 1.0 | 53 (33–78) | 0.9 (0.8–1.1) |
| 16 | 13 | 14 | PSF T2-L5 | 4 | Ullrich disease | - | 41 | 129 | 0.3 | 59 (41–72) | 0.7 (0.5–0.8) |
| 17 | 9 | 16 | PSF T3-L4 | 5 | Pierre Robin Sequence; acampolic campomelic dysplasia | - | 6 | 94 | 1.1 | 67 (57–93) | 1.1 (0.9–1.4) |
| 18 | 12 | 52 | PSF T6-L1 | 5 | - | UTI | 6 | 58 | 2.8 | 68 (60–81) | 0.9 (0.7–1.1) |
| 19 | 16 | 55 | PSF T5-L4 | 6.5 | - | - | 40 | 123 | 1.3 | 70 (58–87) | 0.7 (0.6–1.0) |
| 20 | 12 | 34 | PSF L4-S1 | 6 | spondylolisthesis | - | 18 | 103 | 0.9 | 56 (49–73) | 0.8 (0.7–0.9) |
No: patient number in sequence of entrance to the study.
ASF: anterior spinal fusion; PSF: posterior spinal fusion.
IVH: intraventricular haemorrhage.
UTI: urinary tract infection.
these parameters are measured intra-operatively.
y: years, kg: kilograms, hr: hours, MAP: mean arterial pressure.
Figure 1Time course of mean (SEM) plasma I-FABP (a) and I-BABP (b) levels in children undergoing spinal fusion surgery (n = 20).
* p<0.05 vs. baseline values.
Figure 2Time course of urinary claudin-3:creatinine ratio of two representative of the last five children undergoing spinal fusion surgery.
Figure 3Translated values of plasma levels of circulating I-FABP and translated values of preceding systemic hypotension (MAP t-½hr) in children undergoing spinal fusion surgery were plotted.
Circulating I-FABP correlated significantly negatively with MAP at ½ hour before blood sampling (n = 89, correlation: −0.726 (p<0.001). Translations of both variables are specific for an individual in such a way that all within-person means correspond to the zeros in the plot. In this way the variation of individual levels are cancelled and the pure association of both variables remains.
Within-person correlations between enterocyte cell damage and preceding systemic hypotension and gastric mucosal hypoperfusion.
|
| MAP t-½hr (mmHg) | PrCO2 (kPa) | Pr-aCO2-gap (kPa) |
|
|
|
| |
|
| −0.726 (P<0.001) | 0.553 (P = 0.040) | 0.585 (P = 0.028) |
|
| −0.483 (P<0.001) | −0.051 (P = 0.862) | −0.079 (P = 0.787) |
Within-person correlations between enterocyte cell damage (plasma I-FABP and I-BABP) and preceding systemic hypotension (mean arterial pressure (MAP) at ½ hour before collection of the blood sample for FABP assessment) and gastric mucosal hypoperfusion (PrCO2, Pr-aCO2-gap at the same moment of blood sampling). N = number of measurements.
Figure 4Area under the curve of plasma I-FABP values (AUCI-FABP) during surgery for six patients with early complications and 14 patients without complications.
Mean AUCI-FABP was significantly higher in patients with complications than in patients without complications (p = 0.032). The horizontal lines indicate the mean AUCI-FABP.